Great to talk to @helenmorganlibdem.bsky.social about our Count Us In campaign and how the @libdems.org.uk can support our call to ensure the National Cancer Plan commits to earlier leukaemia diagnosis

We are calling on Government to stop avoidable delays in leukaemia diagnosis. Thank you @wendychambld.bsky.social for engaging with us on how we can achieve this together #LDconf

Thank you @clivejonesmp.bsky.social for speaking to us at our stand at #LDConf. It was good to discuss the need for the National Cancer Plan to save and improve the lives of all cancer patients, including those affected by leukaemia.

A shocking 1 in 4 leukaemia patients face avoidable delays in their diagnosis. Let’s change that! 💪 Join us in calling for the Government to commit to taking action in the upcoming National Cancer Plan ➡️ action.leukaemiauk.org.uk/count-us-in #CountUsIn

Great to talk to @tommorrisonmp.bsky.social about our Count Us In campaign and how he can support our call to ensure the National Cancer Plan commits to earlier leukaemia diagnosis

It was great to meet with @Idbrianmathewmp.bsky.social to discuss our Count Us In campaign. We discussed the need for the National Cancer Plan to address avoidable delays in diagnosis #LDConf

Thank you to our friends from @teenagecancertrust.bsky.social who visited our stand to discuss the need for earlier and faster diagnosis for young people with cancer and also hear our supporter’s Karis personal experience

Day3 at #LDConf - 1 in 4 leukaemia patients face an avoidable delay. If you are at the conference come by to discuss how we can change this

It was great to meet with @jamiegreeneuk.bsky.social and discuss the challenges in diagnosing leukaemia earlier in Scotland.

It was great to meet with @munirawilson.bsky.social to discuss our Count Us In campaign. We discussed the need for the National Cancer Plan to address avoidable delays in diagnosis .

We are calling on Government to stop avoidable delays in leukaemia diagnosis. Thank you @benmaguiremp.bsky.social and Andrew George for engaging with us on how we can achieve this together #LDconf

Thank you @libdemcam.bsky.social for discussing with us the shocking reality people with leukaemia face in their diagnosis and for offering to write to the Government asking them to address this in the National Cancer Plan #LDConf

It was great to speak @freddievanmierlomp.bsky.social about the importance of referring people with symptoms for urgent full blood counts to diagnose (or rule out) leukaemia earlier. Thank you for visiting our stand #LDConf

We are calling on Government to commit to the National Cancer Plan to stopping avoidable delays in leukaemia diagnosis. Thank you @monicaharding.bsky.social and @bobbywdean.bsky.social for discussing with us how you can support our call

Thank you to @mp4stratford.bsky.social for visiting our stand to discuss how we can work together to drive earlier, better leukaemia diagnosis #LDconf

Thank you to @mp4stratford.bsky.social for visiting our stand to discuss how we can work together to drive earlier, better leukaemia diagnosis #LDconf

We had a paw-sitively wonderful visitor at our stand today - A guide dog stealing the show at #LDConf (and our hearts)! 🧡

This morning @claireyoungmp.bsky.social visited our stand, backing our call for the Department of Health and Social Care to address avoidable delays in leukaemia diagnosis in the upcoming national cancer plan

Day 2 of the #LDConf. Visit our stand to find out more about our new campaign and the shocking findings that a quarter of leukaemia patients face avoidable delays in their diagnosis #CountUsIn

Great to talk to @luketaylorld.bsky.social about our Count Us In campaign and how he can support our call to ensure the National Cancer Plan commits to earlier leukaemia diagnosis

Thank you @lizjarvis.bsky.social for speaking to us about the devastating impact of leukaemia and the need to ensure patients are diagnosed at the earliest opportunity

Thank you @victoria-collins.bsky.social for support our Count Us In campaign. It is important that the National Cancer Plan commits to improving earlier diagnosis of leukaemia

Great to meet with @alexkbrewer.bsky.social to discuss our Count Us In campaign. Encouraging to hear her concern about avoidable delays in leukaemia diagnosis and the importance of the National Cancer Plan in addressing these.

First stop: Bournemouth for the @libdems.org.uk. We’re bringing our Count Us In campaign, calling for earlier & better leukaemia diagnosis. Visit our stand to find out more.

📢 EXCLUSIVE: Over a quarter (26%) of leukaemia patients in England experience avoidable delays in their diagnosis, resulting in a significant impact on patient outcomes and NHS resources, according to the results of a study commissioned by Leukaemia UK. 👇 (1/2)

Thank you @leukaemiauk.bsky.social for the invitation to #WCD2025. 😋 It was great to share some of our work and humbling to hear the story of 4 year old Billie the Brave. Congrats on raising so much in one evening for life changing leukaemia research! ❤️

Fantastic news! Blinatumomab - a vital immunotherapy drug for B-cell acute lymphoblastic leukaemia (B-ALL) - has now been approved for use in adults in Scotland, offering new hope for those facing this rare and aggressive type of blood cancer. 🧡 www.dailymail.co.uk/wires/pa/art...

A fantastic keynote lecture from @bethpsaila.bsky.social, Professor of Haematology @imm.ox.ac.uk @ox.ac.uk, for our final talk of the day. 💬

“There’s no way I’d be sitting in front of you now if I didn’t receive the John Goldman Fellowship.” Some established researchers share their experiences and advice for those starting out in the field. 🔬🧡

An incredibly inspiring and thought-provoking Q&A session with some of our John Goldman Fellows and Leukaemia UK Community Champions. ✨ @simonrichardson.bsky.social @scicambridge.bsky.social @manchester.ac.uk @uom-dcs.bsky.social

Professor Francesco Forconi @unisouthampton.bsky.social @uhsft.bsky.social is the first recipient of our Patient Care Pioneer Award. 👏 He joins us virtually to speak about his work developing a risk-assessment tool for chronic lymphocytic leukaemia (CLL).

Next up is Professor David Vetrie @uofglasgow.bsky.social speaking about his research into chronic myeloid leukaemia (CML) 🩸

An insightful talk from Dr Kostas Tzelepis @cam.ac.uk on the therapeutic targeting of epitranscriptome-associated proteins 👨‍🔬

Dr Sophie Kellaway @uniofnottingham.bsky.social delivers our first talk of the day on her research into RUNX1-mutated AML.

It’s #WorldLeukaemiaDay and the return of our Annual Science Seminar @rsc.org. 🔬🧪 We can’t wait to hear about all of the exciting developments in blood cancer research over the past year. 🩸

An incredible discovery in CLL and lymphoma treatment! 🔬🩸 Our funded researcher, Dr Matthew Blunt, found that blocking an immune 'off-switch', combined with existing antibody therapies, could significantly help to kill cancer cells in lymph nodes. academic.oup.com/immunotherap...

Would you know how to #SpotLeukaemia? 🩸 Fatigue, unexplained bruising or bleeding, repeated infections, night sweats, bone or joint pain and shortness of breath are all common signs & symptoms. Help us and @leukaemiacare.bsky.social spread the word this #BloodCancerAwarenessMonth.

📢 This is great news - but we need to see more improvements for leukaemia. We’re calling for full blood counts to be offered as part of core phlebotomy services at all Community Diagnostic Centres, to ensure earlier diagnosis and better outcomes.

New paper led by Aimilia Vareli out now. nature.com/articles/s41... The lymphoma microenvironment stops BH3-mimetics working. In vitro/vivo/silico, we find inhibition of NFκB makes BH3-mimetics great again.🧵 @sussexbcr.bsky.social @bsmsmedschool.bsky.social @leukaemiauk.bsky.social @sussexcancer.org

Lucy was diagnosed with AML in September 2021. Since reaching remission, she's cartwheeled every single day (over 1,000!) and is helping us to raise funds for lifesaving leukaemia research through our new Cartwheel for a Cure campaign. 🤸‍♀️ Read her story 👇

Game-changing news for blood cancer patients! Thanks to new legislation, personalised treatments including CAR-T therapy can now be made on-site in hospitals, meaning they can reach patients faster and closer to home. 👏 Read more: www.htworld.co.uk/news/diagnos...

Researchers may have cracked CAR-T therapy for T-cell ALL – an aggressive leukaemia with few options for adults. Using two protein targets (CD1a + CCR9), the team @carrerasijc.bsky.social developed a dual CAR-T that fights cancer without killing healthy T-cells. 👏 ecancer.org/en/news/2670...

We’re delighted to announce that, together with @lymphomaaction.bsky.social, @myelomauk.bsky.social and @england.nhs.uk, we’re developing the first ever national framework to improve diagnosis, treatment & care for people affected by blood cancers. Read more: www.leukaemiauk.org.uk/news/the-fir...

Early signs often seem harmless - but knowing the common symptoms of leukaemia can be lifesaving. 🩸 Brendan’s ‘flu-like’ symptoms turned out to be acute myeloid leukaemia (AML) - one of the most aggressive types of blood cancer. www.expressandstar.com/news/2025/06...

A bit of Friday inspiration from @leukaemiauk.bsky.social. Their blog spotlights groundbreaking studies from researchers supported by the charity: shorturl.at/N2a2u "Each finding is a stepping stone to changing lives" #CharityImpact

We’re proud to be one of the charities collaborating with @amrc-uk.bsky.social to support groundbreaking medical research across the UK. It’s inspiring to see the collective impact of AMRC member charities - investing in universities, the NHS, and nurturing the next generation of R&D talent.

We were pleased to co-host an event in Northern Ireland with @leukaemiacare.bsky.social this week, bringing together clinical and policy experts to discuss how we can work together to drive improvements for leukaemia patients. @health-ni.gov.uk

We attended #EHA2025 where major advances in #leukaemia were shared. 🔬 Menin inhibitors show promise in AML 👴 Age shouldn't limit treatment options 🏠 Push for oral, at-home therapies 🧬 T-ALL: 15 subtypes ID’d for personalised care #BloodCancer #AML #Haematology

Huge congrats to our John Goldman Fellow, Dr Simon Mitchell, on the one year anniversary of the Sussex Cancer Research Centre (SCRC) - an ambitious, collaborative hub supporting new PhD students, pioneering research projects and driving interdisciplinary collaborations. 🎉

We welcome the Government’s investment in R&D and the NHS in today’s #SpendingReview. We will continue pushing for bold commitments through the Rare Cancers Bill and the upcoming 10-Year Cancer Plan — to drive improvements in leukaemia research, diagnosis, treatment and care.